神经退行性疾病中的线粒体功能障碍:机制和相应的治疗策略
Kai Meng1, Haocheng Jia2, Xiaoqing Hou2
1Lin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining 272067, China.
Biomedicines
|February 26, 2025
概括
线粒体功能障碍有助于神经退行性疾病 (NDs),如阿尔茨海默氏症和帕金森病,通过破坏细胞平衡. 针对这些线粒体问题的治疗为预防和治疗ND提供了新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 神经退行性疾病 (NDs) 涉及中枢神经系统和外围神经系统中神经元的渐进性损失.
- 线粒体功能障碍越来越被认为是各种疾病的关键因素,包括ND,心血管疾病,糖尿病和癌症.
研究的目的:
- 审查关于线粒体在神经退行过程中的作用的最新研究.
- 探索链接线粒体功能障碍,氧化应激和神经退行性疾病进展的机制.
- 根据机械学的见解,为NDs提出新的治疗和预防策略.
主要方法:
- 关于线粒体和神经退行症的最新科学文献的综述.
- 分析包括氧化应激,线粒体平衡和线粒体衰变在内的机制.
- 检查特定疾病模型,如阿尔茨海默病中的β-粉样蛋白积累,帕金森病中的多巴胺神经元损伤以及ALS中的SOD1突变.
主要成果:
- 线粒体功能障碍,其特点是能量代谢受损,动态不平衡和异常的线粒体,有助于神经炎症和神经元损伤.
- 特定的途径,如氧化应激,受损的线粒体平衡和受损的线粒体吸收功能,都与AD,PD和ALS的发病有关.
- 了解这些机制为开发有针对性的干预提供了基础.
结论:
- 线粒体功能障碍是神经退行性疾病发展和进展的核心因素.
- 准线粒体通路为神经退行性疾病的新疗法和预防方法提供了有希望的途径.
- 对线粒体机制的进一步研究对于推进神经退行性疾病的治疗至关重要.
相关概念视频
Electron Transport Chain: Complex I and II
10.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.1K
Parkinson's Disease: Overview
421
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
421
ATP Synthase: Mechanism
13.8K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
13.8K
Mitochondria
9.5K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
9.5K
Mitochondrial Membranes
7.1K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
7.1K
Alzheimer's Disease: Overview
422
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
422


